MedPath

Carbon-ion radiotherapy for solitary lymph node recurrence: a retrospective multicenter observational study

Not Applicable
Conditions
Solitary lymph node recurrence
Registration Number
JPRN-UMIN000027300
Lead Sponsor
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology
Brief Summary

A total of 323 patients were enrolled. The 2-year local control (LC) and overall survival (OS) rates after C-ion RT were 85% and 63%, respectively. Only 1 patient developed grade 3 toxicity. Factors such as LN diameter, histology, and history of previous RT did not correlate with LC. Smaller diameters (<30 mm) and numbers of LN metastases as well as longer disease-free intervals post-primary therapy were associated with significantly better OS.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
323
Inclusion Criteria

Not provided

Exclusion Criteria

1)Tumor invasion to GI tract. 2)Severe or active nfections in the irradiated area. 3)Severe concomitant illness.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
2-year local control, course-specfic survival, and overall survival rates. Incidence of Grade 2 or worse late toxicities
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath